ATE377599T1 - Verfahren zur herstellung von substituierten 5- aminopyrazolo(4,3-e)-1,2,4-triazolo(1,5- c)pyrimidinen - Google Patents

Verfahren zur herstellung von substituierten 5- aminopyrazolo(4,3-e)-1,2,4-triazolo(1,5- c)pyrimidinen

Info

Publication number
ATE377599T1
ATE377599T1 AT04812380T AT04812380T ATE377599T1 AT E377599 T1 ATE377599 T1 AT E377599T1 AT 04812380 T AT04812380 T AT 04812380T AT 04812380 T AT04812380 T AT 04812380T AT E377599 T1 ATE377599 T1 AT E377599T1
Authority
AT
Austria
Prior art keywords
triazolo
aminopyrazolo
pyrimidines
producing substituted
substituted
Prior art date
Application number
AT04812380T
Other languages
English (en)
Inventor
Shen-Chun Kuo
Loc Tran
Pengyi Zhang
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE377599T1 publication Critical patent/ATE377599T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT04812380T 2003-12-01 2004-11-29 Verfahren zur herstellung von substituierten 5- aminopyrazolo(4,3-e)-1,2,4-triazolo(1,5- c)pyrimidinen ATE377599T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52592503P 2003-12-01 2003-12-01

Publications (1)

Publication Number Publication Date
ATE377599T1 true ATE377599T1 (de) 2007-11-15

Family

ID=34652398

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04812380T ATE377599T1 (de) 2003-12-01 2004-11-29 Verfahren zur herstellung von substituierten 5- aminopyrazolo(4,3-e)-1,2,4-triazolo(1,5- c)pyrimidinen

Country Status (8)

Country Link
US (3) US7235659B2 (de)
EP (1) EP1689749B1 (de)
JP (1) JP2007513091A (de)
AT (1) ATE377599T1 (de)
CA (1) CA2547248A1 (de)
DE (1) DE602004009962T2 (de)
ES (1) ES2293380T3 (de)
WO (1) WO2005054245A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ522326A (en) * 2000-05-26 2006-03-31 Schering Corp Adenosine A2A receptor antagonists
US7223861B2 (en) * 2003-10-28 2007-05-29 Schering Corporation Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidines
EP1902716A4 (de) * 2005-06-07 2009-05-13 Kyowa Hakko Kirin Co Ltd Prophylaktisches und/oder therapeutisches mittel für motorische störungen
ES2273599B1 (es) 2005-10-14 2008-06-01 Universidad De Barcelona Compuestos para el tratamiento de la fibrilacion auricular.
US8188098B2 (en) 2008-05-19 2012-05-29 Hoffmann-La Roche Inc. GPR119 receptor agonists
TW201100427A (en) 2009-03-31 2011-01-01 Arqule Inc Substituted heterocyclic compounds
US8926561B2 (en) 2009-07-30 2015-01-06 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
WO2012129381A1 (en) 2011-03-22 2012-09-27 Concert Pharmaceuticals Inc. Deuterated preladenant
WO2012127472A1 (en) * 2011-03-22 2012-09-27 Mapi Pharma Ltd. Process and intermediates for the preparation of preladenant and related compounds
WO2013024474A1 (en) * 2011-08-18 2013-02-21 Mapi Phrarma Ltd. Polymorphs of preladenant
CN113329791A (zh) 2018-11-30 2021-08-31 默沙东公司 作为腺苷受体拮抗剂的9-取代的氨基三唑并喹唑啉衍生物、药物组合物及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264901B1 (it) * 1993-06-29 1996-10-17 Schering Plough S P A Analoghi eterociclici di 1,2,4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina
NZ522326A (en) 2000-05-26 2006-03-31 Schering Corp Adenosine A2A receptor antagonists

Also Published As

Publication number Publication date
CA2547248A1 (en) 2005-06-16
US20070238874A1 (en) 2007-10-11
JP2007513091A (ja) 2007-05-24
ES2293380T3 (es) 2008-03-16
US20090131663A1 (en) 2009-05-21
US7235659B2 (en) 2007-06-26
US7507822B2 (en) 2009-03-24
EP1689749A2 (de) 2006-08-16
EP1689749B1 (de) 2007-11-07
US20060149060A1 (en) 2006-07-06
WO2005054245A2 (en) 2005-06-16
WO2005054245A3 (en) 2005-08-11
DE602004009962T2 (de) 2008-08-28
DE602004009962D1 (de) 2007-12-20

Similar Documents

Publication Publication Date Title
CY1106393T1 (el) Μεθοδος παρασκευης υποκατεστημενων 5-αμινο-πυραζολο [4,3-ε]-1,2,4-τριαζολο [1,5-c]πυριμιδινων
NO20053955D0 (no) Pyrazolo [1,5-A] pyrimidinderivater
ATE498621T1 (de) Verfahren zur herstellung substituierter pyrimidine
ATE377599T1 (de) Verfahren zur herstellung von substituierten 5- aminopyrazolo(4,3-e)-1,2,4-triazolo(1,5- c)pyrimidinen
DE60007257D1 (de) Verfahren zur Herstellung von Cucurbituril Derivaten
SG133602A1 (en) Pyrrolo [2,3-d] pyrimidine compounds for treating transplant rejection
MX2007008131A (es) Proceso para preparar 2-metil-1-(2-metilpropil)-1h-imidazo[4,5-c][ 1,5]naftiridin-4-amina.
DE50008864D1 (de) Verfahren zur herstellung polyisobutenphenol-haltiger mannichaddukte
PL379009A1 (pl) Pochodne pirazolo [1,5-a] [1,3,5] triazyny jako ligandy receptora kanabinoidowego
IS8192A (is) Pýrróló[3,4-c] pýrasól afleiður virkar sem kínasahindrar
ATE500258T1 (de) Verfahren zur herstellung von olanzapin form i
EP1383769A4 (de) Als cyclinabhängige kinase-inhibitoren geeignete 6-substituierte pyrazolo-3,4-d]pyrimidin-4-one
DE60103416D1 (de) Verfahren zur herstellung von 2-alkoxy-6-trifluoromethyl-n-([1,2,4]triazolo[1,5-c]pyrimidin-2-yl)benzolsulfonamiden
DE602004021126D1 (de) Verfahren zur herstellung von n-amino-substituierten heterocyclischen verbindungen
DE60102375D1 (de) Verfahren zur herstellung von 2-amino-5,8-dimethoxy[1,2,4]triazolo[1,5-c]pyrimidine
DE69930416D1 (de) Cgmp pde5 inhibitoren zur inhalationsbehandlung von sexueller dysfunktion
DE60008334D1 (de) Verfahren zur herstellung von 3-hydroxy-tetrahydrofuran
ATE269339T1 (de) Verfahren zur herstellung von (3as)-5,5-dioxo-2,3,3a,4-tetrahydro-1h-pyrrolo( ,1-c)(1,2, 4)benzothiadiazin
DE50103231D1 (de) Verfahren zur herstellung von 7-(pyrazol-3-yl)benzoxazolen
ATE395334T1 (de) Verfahren zur herstellung von (3-oxo-2,3-dihydro- 1h-isoindol-1-yl)-acetylguanidin-derivaten
ATE413405T1 (de) Verfahren zur herstellung von 3- aminothienopyridon-derivaten
ATE382622T1 (de) Verfahren zur herstellung von triazolopyrimidinen
ATE417047T1 (de) Verfahren zur herstellung von 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dih dro-1h-pyrrolizin-5- yl-essigsäure
ATE269334T1 (de) Verfahren zur herstellung von substituiertem (1, 4)diazepino(6,7,1-hi)indol-4-one
DE60205017D1 (de) Verfahren zur Herstellung 2-hydroxymethyl-2, 3- dihydro-thieno(3, 4-b) (1, 4) dioxine-5, 7-dicarbonsaürediester

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties